Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-04 4:21 pm Purchase | 2026-01-29 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 10,100,615 9.990% | 10,100,615 (New Position) | Filing History |
| 2026-02-02 9:16 pm Purchase | 2026-01-28 | 13G | Reliance Global Group, Inc. RELI | Mitchell P. Kopin | 942,906 4.990% | 942,906 (New Position) | Filing History |
| 2026-02-02 8:29 pm Purchase | 2026-01-27 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 71,246 4.990% | 39,893 (+127.24%) | Filing History |
| 2026-01-23 4:25 pm Purchase | 2026-01-15 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 6,002,185 8.200% | 6,002,185 (New Position) | Filing History |
| 2026-01-02 4:55 pm Purchase | 2025-12-29 | 13G | SOBR Safe, Inc. SOBR | Mitchell P. Kopin | 188,818 9.990% | 188,818 (New Position) | Filing History |
| 2026-01-02 4:54 pm Purchase | 2025-12-24 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 147,059 5.500% | 144,725 (+6200.73%) | Filing History |
| 2025-12-29 7:48 pm Purchase | 2025-12-19 | 13G | LM Funding America, Inc. LMFA | Mitchell P. Kopin | 1,166,207 7.600% | 760,767 (+187.64%) | Filing History |
| 2025-12-17 8:20 pm Purchase | 2025-12-11 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 31,353 4.990% | 31,353 (New Position) | Filing History |
| 2025-12-17 8:19 pm Purchase | 2025-12-11 | 13G | GRI Bio, Inc. GRI | Mitchell P. Kopin | 24,196 9.990% | 22,758 (+1582.71%) | Filing History |
| 2025-11-14 5:10 pm Purchase | 2025-11-07 | 13G | Actelis Networks, Inc. ASNS | Mitchell P. Kopin | 193,983 9.990% | 193,983 (New Position) | Filing History |
| 2025-11-14 5:09 pm Purchase | 2025-11-12 | 13G | Decoy Therapeutics Inc. DCOY | Mitchell P. Kopin | 187,295 4.990% | 187,295 (New Position) | Filing History |
| 2025-11-07 5:30 pm Purchase | 2025-09-30 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Mitchell P. Kopin | 113,886 9.990% | 20,779 (+22.32%) | Filing History |
| 2025-11-07 5:30 pm Sale | 2025-09-30 | 13G | Soluna Holdings, Inc. SLNH | Mitchell P. Kopin | 0 0.000% | -2,997,785 (Position Closed) | Filing History |
| 2025-11-07 5:30 pm Purchase | 2025-09-30 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 1,384,410 9.990% | 546,329 (+65.19%) | Filing History |
| 2025-11-07 5:29 pm Purchase | 2025-09-30 | 13G | Purple Biotech Ltd. PPBT | Mitchell P. Kopin | 200,453,695 9.990% | 60,821,220 (+43.56%) | Filing History |
| 2025-11-07 5:29 pm Sale | 2025-09-30 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 695,715 9.990% | -19,129 (-2.68%) | Filing History |
| 2025-11-07 5:27 pm Sale | 2025-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 430,000 7.000% | -100,171 (-18.89%) | Filing History |
| 2025-11-07 5:27 pm Purchase | 2025-09-30 | 13G | Netcapital Inc. NCPL | Mitchell P. Kopin | 501,781 9.300% | 213,904 (+74.30%) | Filing History |
| 2025-11-07 5:26 pm Sale | 2025-09-30 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 0 0.000% | -4,200,951 (Position Closed) | Filing History |
| 2025-11-07 5:26 pm Purchase | 2025-09-30 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 507,724 9.990% | 31,996 (+6.73%) | Filing History |